Bicycle Therapeutics Plc (BCYC)
6.46
-0.16
(-2.42%)
USD |
NASDAQ |
Jan 15, 13:05
Bicycle Therapeutics SG&A Expense (TTM): 80.05M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.354M |
| NuCana Plc | 9.964M |
| Mereo BioPharma Group Plc | 25.26M |
| Autolus Therapeutics Plc | 129.58M |
| DBV Technologies SA | 28.71M |